Clinical trial
A Phase 2 Study of Valproic Acid and Radiation, Followed by Maintenance Valproic Acid and Bevacizumab in Children With Newly Diagnosed High-grade Gliomas or Brainstem Gliomas
NCT00879437 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of Valproic Acid and Radiation, Followed by Maintenance Valproic Acid and Bevacizumab in Children With Newly Diagnosed High-grade Gliomas or Brainstem Gliomas
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 1, 2009
- Completion date
- October 2, 2017
- Enrollment
- 38 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
anaplastic astrocytoma, brainstem glioma, diffuse intrinsic pontine glioma, glial cell tumors, glioblastoma multiforme, gliomatosis cerebri, gliosarcoma, malignant gliomas